Washington, DC, Sept. 06, 2025 (GLOBE NEWSWIRE) — Link to ThinkCareBelieve's Article: https://thinkcarebelieve.blog/2025/09/06/week-33-of-america-with-trump-in-power/ Link to ThinkCareBelieve's Article on Tariffs: https://thinkcarebelieve.blog/2025/09/04/tariffs-will-pay-off-the-national-debt/ ThinkCareBelieve has published an article on Week 33 of the Trump Administration's 2nd term in office. Strong advancement was the theme this week establishing America's security. President Trump greeted President Nawrocki of the Republic of […]

ThinkCareBelieve: Week 33 of America with Trump in Power GlobeNewswire September 06, 2025 Washington, DC, Sept. 06, 2025 (GLOBE NEWSWIRE) — Link to ThinkCareBelieve's Article: https://thinkcarebelieve.blog/2025/09/06/week-33-of-america-with-trump-in-power/ Link to ThinkCareBelieve's Article on Tariffs: https://thinkcarebelieve.blog/2025/09/04/tariffs-will-pay-off-the-national-debt/ ThinkCareBelieve has published an article on Week 33 of the Trump Administration's 2nd term in office. Strong advancement was the theme this

NEW YORK CITY, NY / ACCESS Newswire / September 6, 2025 / WHY: New York, N.Y., September 6, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) between May 12, 2022 and September 22, 2022, both dates inclusive (the "Class Period"), of the important

New data from Phase 3 PEGASUS study demonstrates a 49.7% decrease in mean blood Phe levels in adolescents aged 12-17 treated with PALYNZIQ BioMarin's planned submission to global health authorities on track for second half of 2025 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced new data characterizing the efficacy and safety of PALYNZIQ® (pegvaliase-pqpz) for

More than 1,500 passionate walkers gathered at Toronto's Harbourfront Centre for a half-marathon walk as The Princess Margaret Cancer Foundation (The PMCF), hosted The Walk to Conquer Cancer, a physical challenge and fundraising mission dedicated to creating a world free from the fear of cancer. Thanks to a committed and passionate group of walkers, donors,

NEW YORK CITY, NY / ACCESS Newswire / September 6, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neogen Corporation (NASDAQ:NEOG) between January 5, 2023 and June 3, 2025, inclusive (the "Class Period"), of the important September 16, 2025 lead plaintiff deadline. SO WHAT: If

Robbins Geller Rudman & Dowd LLP announces that the Charter Communications class action lawsuit – captioned Sandoval v. Charter Communications, Inc., No. 25-cv-06747 (S.D.N.Y.) – seeks to represent purchasers or acquirers of Charter Communications, Inc. (NASDAQ: CHTR) securities, including purchasers of call options or sellers of put options and charges Charter Communications and certain of

SAN FRANCISCO, Sept. 06, 2025 (GLOBE NEWSWIRE) — 23andMe Research Institute, Troper Wojcicki Philanthropies (TWP), and Lifebit today announced the official launch of an open-source data platform for the Lung Cancer Genetics Study. Launched in 2024, the Lung Cancer Genetics Study aims to enroll 10,000 individuals diagnosed with lung cancer by 2027. The study already

(NYSE:RBLX), NEW YORK, Sept. 06, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Roblox Corporation (“Roblox” or the “Company”) (NYSE: RBLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Roblox and certain of its officers and/or directors have engaged

(NASDAQ:SLNO), NEW YORK, Sept. 06, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ: SLNO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Soleno and certain of its officers and/or directors have